You or someone in your family may have purchased or acquired the publicly traded common stock of Array BioPharma Inc. during the period of June 30, 2016 to March 17, 2017, inclusive.
The Court ordered that the Notice be sent to you because you have a right to know about a proposed settlement of a class action lawsuit, and your options, before the Court decides whether to approve the settlement. If the Court approves it and after any objections or appeals are resolved, the Settlement Administrator appointed by the Court will make the payments that the settlement allows.
The package explains the lawsuit, the settlement, your legal rights, what benefits are available, who is eligible for them, and how to get them.
The Court in charge of the case is the United States District Court for the District of Colorado, and the case is known as Voulgaris, et al. v. Array BioPharma Inc. et al., Case No. 1:17-cv-02789-KLM. The people who sued are called the Plaintiffs, and the companies and the individuals they sued, Array BioPharma, Inc. (“Array”), Ron Squarer, Victor Sandor, and Jason Haddock, are called Defendants.